MiraVista Diagnostics, is expanding its operations in Central Indiana, creating up to 31 new jobs by 2021.
The Indianapolis-based company, which processes more than 100,000 fungal infection tests annually, will invest more than $5.3 million to expand and equip its headquarters at 4705 Decatur Blvd., doubling the size of its current facility to 48,000 square feet. Expected to be operational in December 2019, MiraVista will grow its on-site infectious disease diagnostic laboratory allowing the company to diversify its testing services to other diseases and scale up the R&D and production of in-vitro diagnostic devices. The company will break ground on the expansion later this month.
“The City of Indianapolis and Decatur Township have been great places to grow and provide diagnostic testing services both nationally and globally,” Dr. Lawrence Joseph Wheat, founder of MiraVista, said in a recent press release. “As the second largest exporter of life sciences products in the U.S., only behind California, it’s been a tremendous source of pride to contribute to Indiana’s robust research and life sciences industries.
“The state and city continue to demonstrate a strong commitment to attracting and keeping businesses and talent here in Indiana.”
